Skip to Content
Merck
  • Orbitofrontal dopamine depletion upregulates caudate dopamine and alters behavior via changes in reinforcement sensitivity.

Orbitofrontal dopamine depletion upregulates caudate dopamine and alters behavior via changes in reinforcement sensitivity.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2014-05-30)
H F Clarke, R N Cardinal, R Rygula, Y T Hong, T D Fryer, S J Sawiak, V Ferrari, G Cockcroft, F I Aigbirhio, T W Robbins, A C Roberts
ABSTRACT

Schizophrenia is associated with upregulation of dopamine (DA) release in the caudate nucleus. The caudate has dense connections with the orbitofrontal cortex (OFC) via the frontostriatal loops, and both areas exhibit pathophysiological change in schizophrenia. Despite evidence that abnormalities in dopaminergic neurotransmission and prefrontal cortex function co-occur in schizophrenia, the influence of OFC DA on caudate DA and reinforcement processing is poorly understood. To test the hypothesis that OFC dopaminergic dysfunction disrupts caudate dopamine function, we selectively depleted dopamine from the OFC of marmoset monkeys and measured striatal extracellular dopamine levels (using microdialysis) and dopamine D2/D3 receptor binding (using positron emission tomography), while modeling reinforcement-related behavior in a discrimination learning paradigm. OFC dopamine depletion caused an increase in tonic dopamine levels in the caudate nucleus and a corresponding reduction in D2/D3 receptor binding. Computational modeling of behavior showed that the lesion increased response exploration, reducing the tendency to persist with a recently chosen response side. This effect is akin to increased response switching previously seen in schizophrenia and was correlated with striatal but not OFC D2/D3 receptor binding. These results demonstrate that OFC dopamine depletion is sufficient to induce striatal hyperdopaminergia and changes in reinforcement learning relevant to schizophrenia.

MATERIALS
Product Number
Brand
Product Description

Isoflurane, European Pharmacopoeia (EP) Reference Standard
Carprofen for system suitability, European Pharmacopoeia (EP) Reference Standard
Carprofen, European Pharmacopoeia (EP) Reference Standard
Supelco
Carprofen, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
6-Hydroxydopamine hydrochloride, ≥97% (titration), powder
Supelco
Carprofen, VETRANAL®, analytical standard